Corporate governance
Novartis is fully committed to good corporate governance. The Group’s principles and rules on corporate governance are laid down in the Articles of Incorporation, the Regulations of the Board and the Charters of the Board Committees.
The Board’s Corporate Governance Committee reviews these principles and rules regularly in light of prevailing best practices and forwards suggestions for improvement to the full Board for approval.
Novartis will provide all shareholders with a printed copy of our Annual Report or 20-F free of charge. These documents contain our complete audited financial statements. Please use the following order form to complete your request.
Download the Annual Report 2007
Corporate Governance Section page 103 (3.6MB)
| Regulations of the Board (full version including both the regulations and all committee charters) |
English (112 kB) |
| Chairman's Committee Charter | English (34 kB) |
| Compensation Committee Charter | English (34 kB) |
| Audit and Compliance Committee Charter | English (55 kB) |
| Corporate Governance and Nomination Committee Charter | English (48 kB) |
| Appendix: Independence Criteria for the Board of Directors and its Committees | English (49 kB) |
| Hiring Restrictions for Auditors | English (52 kB) |
| Audit and Compliance Committee Pre-Approval Policy | English (63 kB) |
| Pre-approval Framework: Audit Services | English (54 kB) |
| Novartis Code of Ethical Conduct for CEO and Senior Financial Officers | English (60 kB) |
About Novartis
We provide medicines to treat and prevent diseases, ease suffering and improve quality of life.
Business conduct
We strive for high performance with high integrity.
Novartis Foundation for Sustainable Development
The Novartis Foundation for Sustainable Development works to improve quality of life in developing countries.